Literature DB >> 17657847

Clinicopathologic significance of BAG1 and TIMP3 expression in colon carcinoma.

Yu-Xian Bai1, Ji-Lin Yi, Jian-Feng Li, Hong Sui.   

Abstract

AIM: To explore the expression of BAG1 and tissue inhibitor of metalloproteinase 3 (TIMP3) in colon carcinoma and their correlation and clinicopathologic significance.
METHODS: SABC immunohistochemistry was used to detect the expression of BAG1 and TIMP3 in 80 colon carcinoma tissues and 20 normal colonic mucosa.
RESULTS: Positive rate of BAG1 in colon carcinoma tissue (80%) was notably higher compared to normal colonic mucosa (10%) (P < 0.05). However, no significant difference was observed in positive rate of TIMP3 in colon carcinoma tissue (43.75%) as compared with normal colonic mucosa (60%) (P > 0.05). Expression of BAG1 and TIMP3 was strongly associated with colon carcinoma differentiation, Duke's staging, lymph node metastasis and survival rate (P < 0.05), but not associated with gender and age. Moreover, BAG1 expression was not correlated with TIMP3.
CONCLUSION: Our results suggest that over-expression of BAG1 or attenuated expression of TIMP3 may play an important role in genesis and development of colon carcinoma. The protein expression levels of BAG1 and TIMP3 are related to the malignant degree, infiltration and metastasis of colon carcinoma. BAG1 and TIMP3 might be new biological parameters in predicting invasion and metastasis of colon carcinoma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17657847      PMCID: PMC4611225          DOI: 10.3748/wjg.v13.i28.3883

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Tissue inhibitor of metalloproteinase-3 (TIMP-3) gene is methylated in the development of esophageal adenocarcinoma: loss of expression correlates with poor prognosis.

Authors:  S Jane Darnton; Laura J Hardie; Ronald S Muc; Christopher P Wild; Alan G Casson
Journal:  Int J Cancer       Date:  2005-06-20       Impact factor: 7.396

Review 2.  BAG-1, an anti-apoptotic tumour marker.

Authors:  Shou-Ching Tang
Journal:  IUBMB Life       Date:  2002-02       Impact factor: 3.885

3.  Methylation-associated silencing of the tissue inhibitor of metalloproteinase-3 gene suggest a suppressor role in kidney, brain, and other human cancers.

Authors:  K E Bachman; J G Herman; P G Corn; A Merlo; J F Costello; W K Cavenee; S B Baylin; J R Graff
Journal:  Cancer Res       Date:  1999-02-15       Impact factor: 12.701

4.  Expression of BAG-1 protein correlates with aggressive behavior of prostate cancers.

Authors:  Maryla Krajewska; Bruce C Turner; Ahmed Shabaik; Stan Krajewski; John C Reed
Journal:  Prostate       Date:  2006-06-01       Impact factor: 4.104

5.  BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data.

Authors:  P A Townsend; E Dublin; I R Hart; R H Kao; A M Hanby; R I Cutress; R Poulsom; K Ryder; D M Barnes; G Packham
Journal:  J Pathol       Date:  2002-05       Impact factor: 7.996

6.  Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study.

Authors:  J J Sirvent; M C Aguilar; M Olona; A Pelegrí; S Blázquez; C Gutiérrez
Journal:  Histol Histopathol       Date:  2004-07       Impact factor: 2.303

Review 7.  BAG-1--a nucleotide exchange factor of Hsc70 with multiple cellular functions.

Authors:  Simon Alberti; Claudia Esser; Jörg Höhfeld
Journal:  Cell Stress Chaperones       Date:  2003       Impact factor: 3.667

8.  BAG-1 expression in normal and neoplastic endometrium.

Authors:  T Moriyama; R D Littell; R Debernardo; E Oliva; M P Lynch; B R Rueda; L R Duska
Journal:  Gynecol Oncol       Date:  2004-08       Impact factor: 5.482

9.  Down-regulation and promoter methylation of tissue inhibitor of metalloproteinase 3 in choriocarcinoma.

Authors:  Huichen Feng; Annie N Y Cheung; Wei-Cheng Xue; Yanling Wang; Xianghong Wang; Songbin Fu; Qi Wang; Hextan Y S Ngan; Sai-Wah Tsao
Journal:  Gynecol Oncol       Date:  2004-08       Impact factor: 5.482

10.  Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells.

Authors:  J D Barnes; N J Arhel; S S Lee; A Sharp; M Al-Okail; G Packham; A Hague; C Paraskeva; A C Williams
Journal:  Apoptosis       Date:  2005-03       Impact factor: 4.677

View more
  6 in total

1.  MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression.

Authors:  Bao Song; Chuanxi Wang; Jie Liu; Xingwu Wang; Liyan Lv; Ling Wei; Li Xie; Yan Zheng; Xianrang Song
Journal:  J Exp Clin Cancer Res       Date:  2010-03-27

2.  Distinct profiles of epigenetic evolution between colorectal cancers with and without metastasis.

Authors:  Hai-Xing Ju; Byonggu An; Yasuyuki Okamoto; Keiko Shinjo; Yukihide Kanemitsu; Koji Komori; Takashi Hirai; Yasuhiro Shimizu; Tsuyoshi Sano; Akira Sawaki; Masahiro Tajika; Kenji Yamao; Makiko Fujii; Hideki Murakami; Hirotaka Osada; Hidemi Ito; Ichiro Takeuchi; Yoshitaka Sekido; Yutaka Kondo
Journal:  Am J Pathol       Date:  2011-03-04       Impact factor: 4.307

3.  Plasma levels of the tissue inhibitor matrix metalloproteinase-3 as a potential biomarker in oral cancer progression.

Authors:  Chun-Wen Su; Bo-Feng Su; Whei-Ling Chiang; Shun-Fa Yang; Mu-Kuan Chen; Chiao-Wen Lin
Journal:  Int J Med Sci       Date:  2017-01-01       Impact factor: 3.738

4.  An ensemble machine learning model based on multiple filtering and supervised attribute clustering algorithm for classifying cancer samples.

Authors:  Shilpi Bose; Chandra Das; Abhik Banerjee; Kuntal Ghosh; Matangini Chattopadhyay; Samiran Chattopadhyay; Aishwarya Barik
Journal:  PeerJ Comput Sci       Date:  2021-09-16

Review 5.  Protein Quality Control in Glioblastoma: A Review of the Current Literature with New Perspectives on Therapeutic Targets.

Authors:  Angela Rocchi; Hassen S Wollebo; Kamel Khalili
Journal:  Int J Mol Sci       Date:  2022-08-27       Impact factor: 6.208

6.  Molecular biological determinations of meningioma progression and recurrence.

Authors:  Stefan Linsler; Dennis Kraemer; Christina Driess; Joachim Oertel; Kai Kammers; Jörg Rahnenführer; Ralf Ketter; Steffi Urbschat
Journal:  PLoS One       Date:  2014-04-10       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.